Vera Therapeutics, Inc. (VERA)
NASDAQ:VERA
Want to see VERA full AI Analyst Report?
VERA Analyst Ratings
Strong Buy
10 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
VERA Stock 12 Month Forecast
Average Price Target
$79.00
▲(86.76% Upside)
| Highest Price Target$110.00 | Average Price Target$79.00 | Lowest Price Target$35.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Guggenheim
$56
Buy
32.39%
Upside
Reiterated
06/03/26
TD Cowen
―
Buy
―
Reiterated
06/02/26
LifeSci Capital
$90
Buy
112.77%
Upside
Reiterated
06/02/26
Raymond James
―
Buy
―
Reiterated
06/02/26
Wolfe Research
$88
Buy
108.04%
Upside
Reiterated
06/02/26
Goldman Sachs
$90
Buy
112.77%
Upside
Reiterated
06/02/26
J.P. Morgan
$90→$86
Buy
103.31%
Upside
Reiterated
05/22/26
Bank of America Securities
$66→$65
Buy
53.66%
Upside
Reiterated
05/22/26
Evercore ISI
$95→$91
Buy
115.13%
Upside
Reiterated
05/15/26
H.C. Wainwright
$110
Buy
160.05%
Upside
Reiterated
05/12/26
Wells Fargo
$70
Buy
65.48%
Upside
Reiterated
11/26/25
Jefferies
$45
Buy
6.38%
Upside
Reiterated
11/26/25
Cantor Fitzgerald
$100
Buy
136.41%
Upside
Reiterated
11/06/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Guggenheim
$56
Buy
32.39%
Upside
Reiterated
06/03/26
TD Cowen
―
Buy
―
Reiterated
06/02/26
LifeSci Capital
$90
Buy
112.77%
Upside
Reiterated
06/02/26
Raymond James
―
Buy
―
Reiterated
06/02/26
Wolfe Research
$88
Buy
108.04%
Upside
Reiterated
06/02/26
Goldman Sachs
$90
Buy
112.77%
Upside
Reiterated
06/02/26
J.P. Morgan
$90→$86
Buy
103.31%
Upside
Reiterated
05/22/26
Bank of America Securities
$66→$65
Buy
53.66%
Upside
Reiterated
05/22/26
Evercore ISI
$95→$91
Buy
115.13%
Upside
Reiterated
05/15/26
H.C. Wainwright
$110
Buy
160.05%
Upside
Reiterated
05/12/26
Wells Fargo
$70
Buy
65.48%
Upside
Reiterated
11/26/25
Jefferies
$45
Buy
6.38%
Upside
Reiterated
11/26/25
Cantor Fitzgerald
$100
Buy
136.41%
Upside
Reiterated
11/06/25
Best Analysts Covering Vera Therapeutics
3 Months
Success Rate
12/25 ratings generated profit
Average Return
+29.52%
Copying Anupam Rama's trades and holding each position for 3 Months would result in 48.00% of your transactions generating a profit, with an average return of +29.52% per trade.
1 Year
Success Rate
14/28 ratings generated profit
Average Return
+57.51%
Copying Rami Katkhuda's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +57.51% per trade.
2 Years
Success Rate
14/25 ratings generated profit
Average Return
+44.27%
Copying Anupam Rama's trades and holding each position for 2 Years would result in 56.00% of your transactions generating a profit, with an average return of +44.27% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
VERA Analyst Recommendation Trends
Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
10
8
8
12
11
Buy
6
5
3
1
3
Hold
1
0
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
17
13
11
14
15
Each month's total comprises the sum of three months' worth of ratings.
VERA Financial Forecast
VERA Stock Forecast FAQ
What is VERA’s average 12-month price target, according to analysts?
Based on analyst ratings, Vera Therapeutics, Inc.’s 12-month average price target is 79.00.
What is VERA’s upside potential, based on the analysts’ average price target?
Vera Therapeutics, Inc. has 86.76% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is VERA a Buy, Sell or Hold?
Vera Therapeutics, Inc. has a consensus rating of Strong Buy which is based on 10 buy ratings, 1 hold ratings and 0 sell ratings.
What is Vera Therapeutics, Inc.’s price target?
The average price target for Vera Therapeutics, Inc. is 79.00. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $110.00 ,the lowest forecast is $35.00. The average price target represents 86.76% Increase from the current price of $42.3.
The highest analyst price target is $110.00 ,the lowest forecast is $35.00. The average price target represents 86.76% Increase from the current price of $42.3.
What do analysts say about Vera Therapeutics, Inc.?
Vera Therapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of VERA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.